English
简体中文
Total: £ 56.28
Published Date: 2025-12-22 | Pages: 79 | Tables: 85 | Pharma & Healthcare
The global market for Maternal Pertussis Vaccine for Newborn Protection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Maternal Pertussis Vaccine for Newborn Protection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Maternal Pertussis Vaccine for Newborn Protection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Maternal Pertussis Vaccine for Newborn Protection include GlaxoSmithKline, Sanofi Pasteur, Intravacc, Zhifei Biological, Walvax, Minhai Biological, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Maternal Pertussis Vaccine for Newborn Protection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Maternal Pertussis Vaccine for Newborn Protection.
The Maternal Pertussis Vaccine for Newborn Protection market size, estimations, and forecasts are provided in terms of sales volume (Dose) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Maternal Pertussis Vaccine for Newborn Protection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Maternal Pertussis Vaccine for Newborn Protection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
GlaxoSmithKline
Sanofi Pasteur
Intravacc
Zhifei Biological
Walvax
Minhai Biological
Segment by Type
Acellular Pertussis Vaccine
Whole-cell Pertussis Vaccine
Segment by Application
Hospital
Centers for Disease Control and Prevention
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Maternal Pertussis Vaccine for Newborn Protection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Maternal Pertussis Vaccine for Newborn Protection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Maternal Pertussis Vaccine for Newborn Protection Market Overview
1.1 Product Definition
1.2 Maternal Pertussis Vaccine for Newborn Protection by Type
1.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Value Comparison by Type (2024 VS 2031)
1.2.2 Acellular Pertussis Vaccine
1.2.3 Whole-cell Pertussis Vaccine
1.3 Maternal Pertussis Vaccine for Newborn Protection by Application
1.3.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Centers for Disease Control and Prevention
1.3.4 Others
1.4 Global Maternal Pertussis Vaccine for Newborn Protection Market Size Estimates and Forecasts
1.4.1 Global Maternal Pertussis Vaccine for Newborn Protection Revenue 2020-2031
1.4.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales 2020-2031
1.4.3 Global Maternal Pertussis Vaccine for Newborn Protection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Maternal Pertussis Vaccine for Newborn Protection Market Competition by Manufacturers
2.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Maternal Pertussis Vaccine for Newborn Protection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Maternal Pertussis Vaccine for Newborn Protection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Maternal Pertussis Vaccine for Newborn Protection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Maternal Pertussis Vaccine for Newborn Protection, Product Type & Application
2.7 Global Key Manufacturers of Maternal Pertussis Vaccine for Newborn Protection, Date of Enter into This Industry
2.8 Global Maternal Pertussis Vaccine for Newborn Protection Market Competitive Situation and Trends
2.8.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Maternal Pertussis Vaccine for Newborn Protection Players Market Share by Revenue
2.8.3 Global Maternal Pertussis Vaccine for Newborn Protection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Maternal Pertussis Vaccine for Newborn Protection Market Scenario by Region
3.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region: 2020-2031
3.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region: 2020-2025
3.2.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region: 2026-2031
3.3 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Region: 2020-2031
3.3.1 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Region: 2020-2025
3.3.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Region: 2026-2031
3.4 North America Maternal Pertussis Vaccine for Newborn Protection Market Facts & Figures by Country
3.4.1 North America Maternal Pertussis Vaccine for Newborn Protection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2020-2031)
3.4.3 North America Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Maternal Pertussis Vaccine for Newborn Protection Market Facts & Figures by Country
3.5.1 Europe Maternal Pertussis Vaccine for Newborn Protection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2020-2031)
3.5.3 Europe Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Market Facts & Figures by Region
3.6.1 Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Sales by Region (2020-2031)
3.6.3 Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Maternal Pertussis Vaccine for Newborn Protection Market Facts & Figures by Country
3.7.1 Latin America Maternal Pertussis Vaccine for Newborn Protection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2020-2031)
3.7.3 Latin America Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Market Facts & Figures by Country
3.8.1 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2020-2031)
4.1.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2020-2025)
4.1.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2026-2031)
4.1.3 Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Type (2020-2031)
4.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Type (2020-2031)
4.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Type (2020-2025)
4.2.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Type (2026-2031)
4.2.3 Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Type (2020-2031)
4.3 Global Maternal Pertussis Vaccine for Newborn Protection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2020-2031)
5.1.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2020-2025)
5.1.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2026-2031)
5.1.3 Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Application (2020-2031)
5.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Application (2020-2031)
5.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Application (2020-2025)
5.2.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Application (2026-2031)
5.2.3 Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Application (2020-2031)
5.3 Global Maternal Pertussis Vaccine for Newborn Protection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Company Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GlaxoSmithKline Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Sanofi Pasteur
6.2.1 Sanofi Pasteur Company Information
6.2.2 Sanofi Pasteur Description and Business Overview
6.2.3 Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
6.2.5 Sanofi Pasteur Recent Developments/Updates
6.3 Intravacc
6.3.1 Intravacc Company Information
6.3.2 Intravacc Description and Business Overview
6.3.3 Intravacc Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Intravacc Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
6.3.5 Intravacc Recent Developments/Updates
6.4 Zhifei Biological
6.4.1 Zhifei Biological Company Information
6.4.2 Zhifei Biological Description and Business Overview
6.4.3 Zhifei Biological Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Zhifei Biological Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
6.4.5 Zhifei Biological Recent Developments/Updates
6.5 Walvax
6.5.1 Walvax Company Information
6.5.2 Walvax Description and Business Overview
6.5.3 Walvax Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Walvax Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
6.5.5 Walvax Recent Developments/Updates
6.6 Minhai Biological
6.6.1 Minhai Biological Company Information
6.6.2 Minhai Biological Description and Business Overview
6.6.3 Minhai Biological Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Minhai Biological Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
6.6.5 Minhai Biological Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Maternal Pertussis Vaccine for Newborn Protection Industry Chain Analysis
7.2 Maternal Pertussis Vaccine for Newborn Protection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Maternal Pertussis Vaccine for Newborn Protection Production Mode & Process Analysis
7.4 Maternal Pertussis Vaccine for Newborn Protection Sales and Marketing
7.4.1 Maternal Pertussis Vaccine for Newborn Protection Sales Channels
7.4.2 Maternal Pertussis Vaccine for Newborn Protection Distributors
7.5 Maternal Pertussis Vaccine for Newborn Protection Customer Analysis
8 Maternal Pertussis Vaccine for Newborn Protection Market Dynamics
8.1 Maternal Pertussis Vaccine for Newborn Protection Industry Trends
8.2 Maternal Pertussis Vaccine for Newborn Protection Market Drivers
8.3 Maternal Pertussis Vaccine for Newborn Protection Market Challenges
8.4 Maternal Pertussis Vaccine for Newborn Protection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Maternal Pertussis Vaccine for Newborn Protection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Maternal Pertussis Vaccine for Newborn Protection Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Maternal Pertussis Vaccine for Newborn Protection Market Competitive Situation by Manufacturers in 2024
Table 4. Global Maternal Pertussis Vaccine for Newborn Protection Sales (Dose) of Key Manufacturers (2020-2025)
Table 5. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Maternal Pertussis Vaccine for Newborn Protection Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Maternal Pertussis Vaccine for Newborn Protection Average Price (US$/Dose) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Maternal Pertussis Vaccine for Newborn Protection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Maternal Pertussis Vaccine for Newborn Protection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Maternal Pertussis Vaccine for Newborn Protection, Product Type & Application
Table 12. Global Key Manufacturers of Maternal Pertussis Vaccine for Newborn Protection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Maternal Pertussis Vaccine for Newborn Protection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Maternal Pertussis Vaccine for Newborn Protection as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region (2020-2025) & (Dose)
Table 18. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Region (2020-2025)
Table 19. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region (2026-2031) & (Dose)
Table 20. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Region (2026-2031)
Table 21. Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Region (2020-2025)
Table 23. Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Region (2026-2031)
Table 25. North America Maternal Pertussis Vaccine for Newborn Protection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2020-2025) & (Dose)
Table 27. North America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2026-2031) & (Dose)
Table 28. North America Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Maternal Pertussis Vaccine for Newborn Protection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2020-2025) & (Dose)
Table 32. Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2026-2031) & (Dose)
Table 33. Europe Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Sales by Region (2020-2025) & (Dose)
Table 37. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Sales by Region (2026-2031) & (Dose)
Table 38. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Maternal Pertussis Vaccine for Newborn Protection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2020-2025) & (Dose)
Table 42. Latin America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2026-2031) & (Dose)
Table 43. Latin America Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2020-2025) & (Dose)
Table 47. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2026-2031) & (Dose)
Table 48. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Maternal Pertussis Vaccine for Newborn Protection Sales (Dose) by Type (2020-2025)
Table 51. Global Maternal Pertussis Vaccine for Newborn Protection Sales (Dose) by Type (2026-2031)
Table 52. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Type (2020-2025)
Table 53. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Type (2026-2031)
Table 54. Global Maternal Pertussis Vaccine for Newborn Protection Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Maternal Pertussis Vaccine for Newborn Protection Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Type (2020-2025)
Table 57. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Type (2026-2031)
Table 58. Global Maternal Pertussis Vaccine for Newborn Protection Price (US$/Dose) by Type (2020-2025)
Table 59. Global Maternal Pertussis Vaccine for Newborn Protection Price (US$/Dose) by Type (2026-2031)
Table 60. Global Maternal Pertussis Vaccine for Newborn Protection Sales (Dose) by Application (2020-2025)
Table 61. Global Maternal Pertussis Vaccine for Newborn Protection Sales (Dose) by Application (2026-2031)
Table 62. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Application (2020-2025)
Table 63. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Application (2026-2031)
Table 64. Global Maternal Pertussis Vaccine for Newborn Protection Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Maternal Pertussis Vaccine for Newborn Protection Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Application (2020-2025)
Table 67. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Application (2026-2031)
Table 68. Global Maternal Pertussis Vaccine for Newborn Protection Price (US$/Dose) by Application (2020-2025)
Table 69. Global Maternal Pertussis Vaccine for Newborn Protection Price (US$/Dose) by Application (2026-2031)
Table 70. GlaxoSmithKline Company Information
Table 71. GlaxoSmithKline Description and Business Overview
Table 72. GlaxoSmithKline Maternal Pertussis Vaccine for Newborn Protection Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 73. GlaxoSmithKline Maternal Pertussis Vaccine for Newborn Protection Product
Table 74. GlaxoSmithKline Recent Developments/Updates
Table 75. Sanofi Pasteur Company Information
Table 76. Sanofi Pasteur Description and Business Overview
Table 77. Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 78. Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Product
Table 79. Sanofi Pasteur Recent Developments/Updates
Table 80. Intravacc Company Information
Table 81. Intravacc Description and Business Overview
Table 82. Intravacc Maternal Pertussis Vaccine for Newborn Protection Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 83. Intravacc Maternal Pertussis Vaccine for Newborn Protection Product
Table 84. Intravacc Recent Developments/Updates
Table 85. Zhifei Biological Company Information
Table 86. Zhifei Biological Description and Business Overview
Table 87. Zhifei Biological Maternal Pertussis Vaccine for Newborn Protection Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 88. Zhifei Biological Maternal Pertussis Vaccine for Newborn Protection Product
Table 89. Zhifei Biological Recent Developments/Updates
Table 90. Walvax Company Information
Table 91. Walvax Description and Business Overview
Table 92. Walvax Maternal Pertussis Vaccine for Newborn Protection Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 93. Walvax Maternal Pertussis Vaccine for Newborn Protection Product
Table 94. Walvax Recent Developments/Updates
Table 95. Minhai Biological Company Information
Table 96. Minhai Biological Description and Business Overview
Table 97. Minhai Biological Maternal Pertussis Vaccine for Newborn Protection Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 98. Minhai Biological Maternal Pertussis Vaccine for Newborn Protection Product
Table 99. Minhai Biological Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Maternal Pertussis Vaccine for Newborn Protection Distributors List
Table 103. Maternal Pertussis Vaccine for Newborn Protection Customers List
Table 104. Maternal Pertussis Vaccine for Newborn Protection Market Trends
Table 105. Maternal Pertussis Vaccine for Newborn Protection Market Drivers
Table 106. Maternal Pertussis Vaccine for Newborn Protection Market Challenges
Table 107. Maternal Pertussis Vaccine for Newborn Protection Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Product Picture of Maternal Pertussis Vaccine for Newborn Protection
Figure 2. Global Maternal Pertussis Vaccine for Newborn Protection Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Maternal Pertussis Vaccine for Newborn Protection Market Share by Type: 2024 & 2031
Figure 4. Acellular Pertussis Vaccine Product Picture
Figure 5. Whole-cell Pertussis Vaccine Product Picture
Figure 6. Global Maternal Pertussis Vaccine for Newborn Protection Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Maternal Pertussis Vaccine for Newborn Protection Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Centers for Disease Control and Prevention
Figure 10. Others
Figure 11. Global Maternal Pertussis Vaccine for Newborn Protection Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Maternal Pertussis Vaccine for Newborn Protection Market Size (2020-2031) & (US$ Million)
Figure 13. Global Maternal Pertussis Vaccine for Newborn Protection Sales (2020-2031) & (Dose)
Figure 14. Global Maternal Pertussis Vaccine for Newborn Protection Average Price (US$/Dose) & (2020-2031)
Figure 15. Maternal Pertussis Vaccine for Newborn Protection Report Years Considered
Figure 16. Maternal Pertussis Vaccine for Newborn Protection Sales Share by Manufacturers in 2024
Figure 17. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Maternal Pertussis Vaccine for Newborn Protection Players: Market Share by Revenue in Maternal Pertussis Vaccine for Newborn Protection in 2024
Figure 19. Maternal Pertussis Vaccine for Newborn Protection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Country (2020-2031)
Figure 22. North America Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Country (2020-2031)
Figure 23. United States Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Country (2020-2031)
Figure 26. Europe Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Country (2020-2031)
Figure 27. Germany Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Region (2020-2031)
Figure 34. China Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Country (2020-2031)
Figure 42. Latin America Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Colombia Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Maternal Pertussis Vaccine for Newborn Protection by Type (2020-2031)
Figure 53. Global Revenue Market Share of Maternal Pertussis Vaccine for Newborn Protection by Type (2020-2031)
Figure 54. Global Maternal Pertussis Vaccine for Newborn Protection Price (US$/Dose) by Type (2020-2031)
Figure 55. Global Sales Market Share of Maternal Pertussis Vaccine for Newborn Protection by Application (2020-2031)
Figure 56. Global Revenue Market Share of Maternal Pertussis Vaccine for Newborn Protection by Application (2020-2031)
Figure 57. Global Maternal Pertussis Vaccine for Newborn Protection Price (US$/Dose) by Application (2020-2031)
Figure 58. Maternal Pertussis Vaccine for Newborn Protection Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
